Serina Therapeutics, Inc. Accumulated Other Comprehensive Income
Serina Therapeutics, Inc. (SER) had Accumulated Other Comprehensive Income of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$8.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$14.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$4.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$8.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$14.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$4.00K 10-Q · filed 2025-11-13 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 |
| 2020-12-31 | $143.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $92.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $81.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $44.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $69.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $74.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $44.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $24.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$2.00K 10-K/A · filed 2020-03-31 |
| 2017-12-31 | $68.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |